{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for m root_references_citation in Reference Text / Citation (approximate match)
Status:
Investigational
Source:
INN:lusacomfar alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03654508: Not Applicable Interventional Completed Asthma in Children
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01342263: Not Applicable Interventional Completed Ischemic Heart Disease
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00471120: Not Applicable Interventional Terminated Uterine Cancer
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03358355: Phase 1/Phase 2 Interventional Completed Peripheral Artery Disease
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03746431: Phase 1/Phase 2 Interventional Recruiting Advanced Solid Tumours
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00732082: Phase 1 Interventional Terminated Pancreatic Neoplasms
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00001296: Phase 3 Interventional Completed Melanoma
(1992)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04655586: Phase 2/Phase 3 Interventional Completed Covid19
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04612530: Phase 1 Interventional Unknown status Pancreatic Cancer
(2020)
Source URL:
Class:
PROTEIN
